AstraZeneca Pharma India Limited (BOM:506820)
India · Delayed Price · Currency is INR 7,628.85
-124.85 (-1.61%)
At close: Aug 17, 2026
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 193.84 billion as of August 17, 2026. Its market cap has decreased by -6.48% in one year.
Market Cap
193.84B
Enterprise Value
190.47B
Revenue
24.32B
Ranking
n/a
PE Ratio
114.28
Stock Price
7,628.85
ChartMarket Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 193.84B, an increase of 13,268.45%. That is a compound annual growth rate of 22.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 190.72B | -15.33% |
| Dec 31, 2025 | 225.25B | 23.26% |
| Dec 31, 2024 | 182.75B | 32.43% |
| Dec 29, 2023 | 138.00B | 67.65% |
| Dec 30, 2022 | 82.31B | 6.20% |
| Dec 31, 2021 | 77.51B | -32.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 575.37B |
| GlaxoSmithKline Pharmaceuticals | 455.55B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 268.01B |
| Granules India | 212.63B |
| Caplin Point Laboratories | 188.55B |
| Jubilant Pharmova | 136.92B |
| CORONA Remedies | 130.71B |